AstraZeneca Expands Bangalore Global Hub, Creating 400 Jobs to Boost R&D, Global Services, AI Innovation

AstraZeneca expands its Bangalore Global Hub, investing in AI-powered innovation across R&D, IT and Digital Health.

New Delhi: AstraZeneca has announced the expansion of its state-of-the-art Global Hub in Bangalore, strengthening its presence in India.

The new facility will house nearly 1300 employees, including 400 new jobs, supporting the company’s capabilities in AI-powered innovation across Research and Development, Global Business Services, IT, as well as Digital Health operations.

This announcement represents AstraZeneca’s second major investment in India within a year, following the expansion of its Global Innovation and Technology Centre (GITC) in Chennai. The combined workforce now at AstraZeneca India Private Limited (AZIPL) will reach close to 4,000 employees, strengthening the company’s capability to deliver life-changing medicines to patients worldwide.

“Our Global Hub in Bangalore is a strategic investment that will play a vital role in advancing AstraZeneca’s bold ambition to deliver 20 new medicines by 2030 — by strengthening automated, scalable, data-driven and patient-centric solutions. This step reflects our commitment to tapping into the world-class talent and ecosystem available in Karnataka to power the next generation of scientific innovation. We are equally committed to decarbonise our operations and value chain, and the hub supports our net zero ambition”, said Jackie Crockford, Vice President, Global Business Services, AstraZeneca.

The new facility will serve as a dynamic hub dedicated to advancing AstraZeneca’s critical priorities:

  • Advanced clinical research supporting AstraZeneca’s global therapeutic areas
  • Development of AI-powered healthcare solutions and digital health technologies
  • Centralised data analytics to enhance clinical trial efficiency and patient outcomes
  • Specialised support for global regulatory compliance and pharmacovigilance

The Karnataka government has welcomed the expansion as a validation of the state’s position as a global innovation hub. “AstraZeneca’s investment reaffirms India’s leadership in science, technology and healthcare, and is a testament to Karnataka’s robust life sciences ecosystem. This expansion aligns perfectly with our vision to create high-value employment opportunities while fostering innovation in critical sectors, making Bangalore a global hub for biotechnology and R&D,” said Honourable Minister Dinesh Gundu Rao, Ministry of Health & Family Welfare, Government of Karnataka.

The Global Hub in Bangalore reflects AstraZeneca’s dedication to environmental sustainability and every aspect of this facility has been carefully planned to make meaningful progress towards a healthier planet. The hub is designed to achieve LEED Platinum certification and is currently powered by 75% green energy. It implements full wastewater recycling, IoT-enabled systems for optimised energy management and much more.

Also Read –
AstraZeneca India Welcomes Praveen Rao Akkinepally as MD